Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Agilon Health (AGL) Income from Continuing Operations (2020 - 2025)

Agilon Health (AGL) has disclosed Income from Continuing Operations for 6 consecutive years, with 188882000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Income from Continuing Operations fell 77.47% year-over-year to 188882000.0, compared with a TTM value of 405347000.0 through Dec 2025, down 61.96%, and an annual FY2025 reading of 405347000.0, down 61.96% over the prior year.
  • Income from Continuing Operations was 188882000.0 for Q4 2025 at Agilon Health, down from 110207000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 9951000.0 in Q1 2023 and bottomed at 297329000.0 in Q2 2021.
  • Average Income from Continuing Operations over 5 years is 66824650.0, with a median of 33643500.0 recorded in 2021.
  • The sharpest move saw Income from Continuing Operations crashed 8530.74% in 2021, then surged 1270.66% in 2023.
  • Year by year, Income from Continuing Operations stood at 35804000.0 in 2021, then dropped by 15.89% to 41495000.0 in 2022, then crashed by 302.79% to 167139000.0 in 2023, then surged by 36.32% to 106430000.0 in 2024, then crashed by 77.47% to 188882000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for AGL at 188882000.0 in Q4 2025, 110207000.0 in Q3 2025, and 104370000.0 in Q2 2025.